Permanente Medical Group CEO: Hospital mega-mergers are 'deals of desperation'

Recently announced health system mergers like the Dignity Health-Catholic Health Initiatives and Ascension-Providence St. Joseph combinations aren’t about long-term growth, argues Permanente Medical Group CEO Robert Pearl, MD, but are rather signs of panic from systems which are banking on increased clout and higher prices to counteract financial struggles and waning influence.

As part of his “Saving America’s Hospitals” series for Forbes, Pearl repeats existing evidence that hospital consolidation has led to higher prices, rather than the often-stated goals of improving quality and lowering costs. It won’t work, he argues, because major healthcare purchasers are “growing inpatient” with exorbitant hospital rates and shifting patient care to less costly settings.

The easy solution for hospital CEOs, he writes, is the one they’re taking: expand services and raise prices. In the long run, however, he feels the answer is going to be consolidating volume in fewer facilities and demand higher efficiency from physicians—what he calls “self-disruption”—or else change will be led by outside forces like insurance companies.

“Few organizations in any industry find consolidation and downsizing attractive. But the alternative, being disrupted by others, will prove far more painful for hospitals,” Pearl writes. “Unless CEOs are willing to embrace strategies that focus on operational efficiency, their bottom lines will continue to erode as patients pursue more convenient and lower priced care elsewhere.”

Read more at the link below:

""
John Gregory, Senior Writer

John joined TriMed in 2016, focusing on healthcare policy and regulation. After graduating from Columbia College Chicago, he worked at FM News Chicago and Rivet News Radio, and worked on the state government and politics beat for the Illinois Radio Network. Outside of work, you may find him adding to his never-ending graphic novel collection.

Around the web

Compensation for heart specialists continues to climb. What does this say about cardiology as a whole? Could private equity's rising influence bring about change? We spoke to MedAxiom CEO Jerry Blackwell, MD, MBA, a veteran cardiologist himself, to learn more.

The American College of Cardiology has shared its perspective on new CMS payment policies, highlighting revenue concerns while providing key details for cardiologists and other cardiology professionals. 

As debate simmers over how best to regulate AI, experts continue to offer guidance on where to start, how to proceed and what to emphasize. A new resource models its recommendations on what its authors call the “SETO Loop.”